HLTENN007 Medication Program - Administer and monitor medicines and intravenous therapy

 

The Australian Health Professional Regulation Agency (AHPRA) and the Nursing and Midwifery Board of Australia (NMBA) require evidence that Enrolled Nurses have successfully completed medication administration education, to ensure the safe administration of medications.

ENs wishing to remove a notation on their registration or update their qualification to allow medication delivery in the workplace must complete the unit of study; HLTENN007 Administer and monitor medicines and intravenous therapy. This is a unit that is provided within an NMBA-approved Diploma of Nursing course.


 

2021
Intakes

Early 2021,
expressions of interest now open



 

Program

Course Duration

Determined by self-directed learning
Expected length of time is 18 - 26 weeks

Course Location

This unit is delivered by ANMEC in an online delivery mode. ANMEC make this an achievable process for EN’s currently working in the clinical setting.

Entry Requirements
RPL for some components may be available for Enrolled Nurses who can demonstrate current skills and knowledge as performed in their workplace.
Applicants must be:
  1. Applicants must be currently registered with the Australian Health Practitioner Regulation Agency (AHPRA) and can supply evidence of current AHPRA registration;
  2. Must be currently employed and practicing regularly in a clinical environment to achieve the skill requirements for this unit;
  3. Currently under supervision/direct report of an RN manager who can sign recognition documentation to confirm current clinical practice;
  4. Applicants must be over 18 years of age;
  5. Applicants must supply evidence of Enrolled Nurse.
Course Cost

$1,300 full cost for ANMFSA member (full member over 12 months)
$2,300 full cost for non-member

Assesments

Skill assessments, simulated patient documentation, medication exam, medicine groups and pathophysiology quiz, drug calculation exam, clinical case studies

Upcoming events